UTILISATION ET COMPOSITION POUR TRAITER LA MYASTHENIE GRAVE ET D'AUTRES SYNDROMES MYASTHENIQUES

• 收藏
• 分享

专利权人:

INC.;GT BIOPHARMA

发明人:

CLARENCE-SMITH, KATHLEEN E.

申请号：

CA3071377

公开号：

CA3071377A1

申请日:

2018.01.08

申请国别(地区):

CA

年份:

2018

代理人:

摘要：

The present invention describes the use of a 5HT3-antagonist, in combination with pyridostigmine, to facilitate the symptomatic treatment of mammalian subjects, and particularly humans, dogs, and cats, suffering from a myasthenic syndrome, notably myasthenia gravis, by providing a therapeutically effective pyridostigmine bromide daily dose without the typical adverse effects.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/